Intanwijaya Internasional Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Intanwijaya Internasional Tbk trades at Rp670 (market cap 140.17B, 600 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (62.5K versus 600). Which is the better fit depends on your goals.
| INCI | OBAT | |
|---|---|---|
Market Cap | 140.17B | 164.65B |
Volume | 600 | 62.5K |
Lot | 6 | 625 |
Turnover | 403K | 15.03M |
Average Price | 671.67 | 240.55 |
Value | 403K | 15.03M |
Indicative Equilibrium Price | — | 238 |
Indicative Equilibrium Volume | — | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Intanwijaya International Tbk (the Company) formerly named as PT Intan Wijaya Chemical Industry Tbk, was established in Jakarta based on the Notarial Deed No. 64 of Jony Frederik Berthold Tumbelaka Sinjal, S.H., dated November 14, 1981.The company's business field in in the Formaldehyde and Formaldehyde Resin Industries with the capacity of 96.000 metrics tons per annum in the form of liquid and 7.000 metric tons per annum in the form of powder and Hexamine 6.000 metric tons per annum.
Read more on INCI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →